The time to return-to-work in healthcare workers with COVID-19 treated with ensitrelvir, a novel oral inhibitor of 3C-like protease of SARS-CoV-2: An observational study utilizing pre-existing data from a single hospital
Katsuta et al., Journal of Infection and Chemotherapy, doi:10.1016/j.jiac.2025.102669
https://c19early.org/katsuta.html